SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-040497
Filing Date
2023-02-16
Accepted
2023-02-15 20:34:06
Documents
16
Period of Report
2023-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d422452d8k.htm   iXBRL 8-K 32481
2 EX-1.2 d422452dex12.htm EX-1.2 25348
3 EX-5.1 d422452dex51.htm EX-5.1 5651
7 GRAPHIC g422452page1.jpg GRAPHIC 9822
8 GRAPHIC g422452page2.jpg GRAPHIC 10817
  Complete submission text file 0001193125-23-040497.txt   219639

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA etnb-20230215.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20230215_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20230215_pre.xml EX-101.PRE 11703
10 EXTRACTED XBRL INSTANCE DOCUMENT d422452d8k_htm.xml XML 3464
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 23636922
SIC: 2834 Pharmaceutical Preparations